Lars Bullinger Selected Research

Lars Bullinger Research Topics

Disease

64	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 11/2023 - 04/2004
52	Neoplasms (Cancer) 04/2024 - 09/2005
33	Leukemia 11/2023 - 08/2007
10	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 01/2023 - 08/2002
8	Lymphoma (Lymphomas) 11/2023 - 09/2005
7	Infections 03/2024 - 10/2020
6	Hematologic Neoplasms (Hematological Malignancy) 10/2023 - 09/2008
6	Multiple Myeloma 09/2023 - 01/2013
5	Carcinogenesis 01/2018 - 09/2008
4	COVID-19 01/2023 - 10/2020
4	Chromosome Aberrations (Chromosome Abnormalities) 12/2016 - 04/2004
3	Inflammation (Inflammations) 11/2023 - 01/2023
3	B-Cell Lymphoma (Lymphoma, B Cell) 11/2023 - 01/2021
3	Non-Hodgkin Lymphoma (Lymphosarcoma) 10/2023 - 01/2019
3	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 10/2023 - 09/2013
3	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 08/2022 - 08/2010
3	Residual Neoplasm 01/2022 - 12/2006
3	Glioblastoma (Glioblastoma Multiforme) 01/2021 - 01/2019
3	Glioma (Gliomas) 01/2018 - 06/2017
2	Ovarian Neoplasms (Ovarian Cancer) 05/2024 - 04/2024
2	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 10/2023 - 07/2015
2	Primary Myelofibrosis (Myelosclerosis) 10/2023 - 01/2020
2	Febrile Neutropenia 07/2023 - 01/2022
2	Pathologic Complete Response 07/2023 - 12/2006
2	Graft vs Host Disease (Graft-Versus-Host Disease) 01/2023 - 11/2019
2	Colorectal Neoplasms (Colorectal Cancer) 08/2022 - 04/2022
2	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 01/2022 - 01/2021
2	Acute Promyelocytic Leukemia 01/2022 - 04/2011
2	Myeloid Leukemia (Leukemia, Myelocytic) 01/2022 - 08/2010
1	Chronic Disease (Chronic Diseases) 04/2024
1	Cachexia 04/2024
1	Wasting Syndrome (Wasting Disease) 04/2024
1	Weight Loss (Weight Reduction) 04/2024
1	Aplastic Anemia (Anemia, Hypoplastic) 01/2024

Drug/Important Bio-Agent (IBA)

13	Proteins (Proteins, Gene)FDA Link 01/2022 - 12/2005
9	Transcription Factors (Transcription Factor)IBA 11/2023 - 02/2009
8	AntigensIBA 09/2023 - 12/2006
8	NucleophosminIBA 01/2019 - 12/2005
7	DNA (Deoxyribonucleic Acid)IBA 05/2024 - 09/2005
7	Core Binding Factors (Core-Binding Factor)IBA 12/2020 - 08/2007
6	MicroRNAs (MicroRNA)IBA 01/2018 - 11/2008
4	Messenger RNA (mRNA)IBA 01/2023 - 12/2011
4	Phosphotransferases (Kinase)IBA 01/2022 - 09/2008
4	RNA (Ribonucleic Acid)IBA 01/2022 - 01/2021
4	midostaurinIBA 01/2022 - 01/2021
4	Tretinoin (Retinoic Acid)FDA LinkGeneric 01/2022 - 01/2009
4	Temozolomide (Temodar)FDA LinkGeneric 01/2021 - 01/2018
4	Decitabine FDA Link 07/2020 - 09/2014
3	ChromatinIBA 11/2023 - 06/2016
3	Immune Checkpoint InhibitorsIBA 02/2023 - 12/2017
3	Chimeric Antigen ReceptorsIBA 01/2023 - 01/2022
3	Peptides (Polypeptides)IBA 11/2022 - 12/2006
3	venetoclaxIBA 09/2022 - 01/2019
3	Tyrosine Kinase InhibitorsIBA 08/2022 - 07/2014
3	Circular RNAIBA 01/2021 - 12/2017
3	Dasatinib (BMS 354825)FDA Link 01/2021 - 02/2014
3	Rituximab (Mabthera)FDA Link 01/2021 - 05/2014
3	Biomarkers (Surrogate Marker)IBA 01/2021 - 08/2008
3	Protein Isoforms (Isoforms)IBA 01/2020 - 12/2017
3	Histones (Histone)IBA 01/2018 - 07/2011
2	VaccinesIBA 03/2024 - 01/2023
2	Telomerase (Telomerase Reverse Transcriptase)IBA 10/2023 - 12/2014
2	HLA-C Antigens (HLA-C)IBA 09/2023 - 11/2022
2	Gemtuzumab (Mylotarg)FDA Link 07/2023 - 01/2022
2	Immunoglobulins (Immunoglobulin)IBA 01/2023 - 08/2002
2	Cytarabine (Cytosar-U)FDA LinkGeneric 09/2022 - 12/2011
2	Lenalidomide (CC 5013)FDA Link 01/2022 - 07/2015
2	palbociclibIBA 01/2022 - 01/2019
2	Retinoic Acid Receptors (Retinoic Acid Receptor)IBA 01/2022 - 05/2013
2	Imatinib Mesylate (Gleevec)FDA Link 01/2022 - 04/2012
2	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 01/2022 - 05/2008
2	Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA 09/2020 - 08/2010
2	Lomustine (CCNU)FDA Link 10/2019 - 01/2019
2	Insulin-Like PeptidesIBA 01/2019 - 09/2011
2	Azacitidine (5 Azacytidine)FDA Link 12/2018 - 01/2018
2	CCAAT-Enhancer-Binding Protein-alphaIBA 02/2011 - 05/2008
1	Heat-Shock Proteins (Heat-Shock Protein)IBA 04/2024
1	Poly(ADP-ribose) Polymerase InhibitorsIBA 04/2024
1	Carboplatin (JM8)FDA LinkGeneric 04/2024
1	Growth Hormone (Somatotropin)IBA 04/2024
1	Insulin-Like Growth Factor I (IGF-1)IBA 04/2024
1	somatotropin-binding protein (growth hormone-binding protein)IBA 04/2024
1	EpitopesIBA 01/2024
1	ProteomeIBA 01/2024
1	InterferonsIBA 11/2023
1	imetelstatIBA 10/2023
1	Fatty Acids (Saturated Fatty Acids)IBA 10/2023
1	tisagenlecleucelIBA 10/2023

Therapy/Procedure

32	Therapeutics 04/2024 - 04/2004
19	Drug Therapy (Chemotherapy) 01/2023 - 08/2007
7	Precision Medicine 11/2023 - 03/2017
6	Transplantation 05/2022 - 12/2016
4	Stem Cell Transplantation 01/2023 - 01/2021
4	Hematopoietic Stem Cell Transplantation 01/2022 - 08/2013
2	Biological Therapy 05/2022 - 01/2022
2	Cell Transplantation 01/2022 - 11/2021
2	Consolidation Chemotherapy 01/2022 - 01/2018
2	Salvage Therapy 01/2021 - 01/2019
2	Immunotherapy 04/2020 - 01/2017
2	Chemoradiotherapy 10/2019 - 01/2019